Evidence map›Paper›PMID 35028526›Full record

ArticleHemaSphere2022

Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.

Roch Houot, Viola Poeschel, Bettina Altmann, Stephanie Angel, Lorenz Thurner, Thomas Illmer, Marc Andre, Martin Dreyling, Hervé Maisonneuve, Hervé Tilly and 19 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 5 countries.

Roch HouotDepartment of Hematology, CHU Rennes, University of Rennes, INSERM U1236, Rennes, France.
Viola PoeschelDepartment of Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany.
Bettina AltmannInstitute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Germany.
Stephanie AngelDepartment of Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany.
Lorenz ThurnerDepartment of Hematology, Oncology and Rheumatology, Saarland University Medical School, Homburg/Saar, Germany.
Thomas IllmerHematology-Oncology Practice, Dresden, Germany.
Marc AndreCHU UCL Namur, Yvoir, Belgium.
Martin DreylingDepartment of Medicine III, LMU Hospital Munich, Germany.
Hervé MaisonneuveClinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France.
Hervé TillyDepartment of Hematology, Centre Henri Becquerel, Rouen, France.
Stephanie MayerDepartment of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
Olivier CasasnovasDepartment of Hematology, CHU Dijon, Dijon, France.
Steven Le GouillDepartment of Hematology, CHU Nantes, Nantes, France.
Fritz OffnerUniversity Hospital Ghent, Gent, Belgium.
Guillaume CartronDepartment of Hematology, CHU Montpellier, Montpellier, France.
Andrea KerkhoffMedizinische Klinik A, Hematology and Oncology, University Hospital Muenster, Germany.
Thomas WeberDepartment of Internal Medicine IV, Hematology and Oncology, University Hospital Halle (Saale), Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.
Joerg HoffmannDepartment of Hematology, Oncology and Immunology, Philipps University Marburg, University Hospital Giessen and Marburg, Germany.
Marita ZiepertInstitute for Medical Informatics, Statistics and Epidemiology, University Leipzig, Germany.
Wolfram KlapperDepartment of Pathology, Hematopathology Section, University of Schleswig-Holstein, Campus Kiel, Germany.
Emmanuel IttiDepartment of Nuclear Medicine, Henri Mondor University Hospitals, AP-HP/U-PEC, Créteil, France.
Dirk HellwigDepartment of Nuclear Medicine, University Hospital Regensburg, Germany.
Giorgi NatchkebiaDepartment of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany.
Laurence de LevalDepartment of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Switzerland.
Andreas RosenwaldInstitute of Pathology, University of Würzburg, Germany.
Corinne HaiounLymphoid Malignancies Unit, Henri Mondor University Hospital, APHP, Créteil, France.
Laurent DercleDepartment of Radiology, Columbia University Irving Medical Center, New York, New York, USA.
Philippe GaulardDepartment of Pathology, Henri Mondor University Hospital, APHP, INSERM U955, Université Paris-Est, Créteil, France.
Gerhard HeldDepartment of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany.
Saarland University · DELeipzig University · DEUniversity Hospital Regensburg · DEWestpfalz Klinikum · DEAssistance Publique – Hôpitaux de Paris · FRCentre Henri BecquerelCentre Hospitalier Départemental Vendée · FRCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire Dijon Bourgogne · FRCHU Dinant Godinne UCL Namur · BEColumbia University Irving Medical Center · USGhent University Hospital · BEHôpitaux Universitaires Henri-Mondor · FRInserm · FRLaboratoire de Thermique et Energie de Nantes · FRLudwig-Maximilians-Universität München · DEMartin Luther University Halle-Wittenberg · DEOnkozentrum Dresden · DEUniversitätsklinikum Gießen und Marburg · DEUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35028526
PMCPMC8751801
OpenAlexW4205947127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.